These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2569359

  • 1. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
    Tong AW, Lee J, Wang RM, Dalton WS, Tsuruo T, Fay JW, Stone MJ.
    Cancer Res; 1989 Sep 01; 49(17):4829-34. PubMed ID: 2569359
    [Abstract] [Full Text] [Related]

  • 2. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
    Tong AW, Dalton WS, Tsuruo T, Fay JW, Stone MJ.
    Prog Clin Biol Res; 1990 Sep 01; 333():155-64. PubMed ID: 2308979
    [Abstract] [Full Text] [Related]

  • 3. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
    Stone MJ, Tong AW, Fay JW, Lee JC.
    Cancer Detect Prev; 1988 Sep 01; 12(1-6):621-35. PubMed ID: 3180147
    [Abstract] [Full Text] [Related]

  • 4. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement.
    Kulkarni SS, Wang ZM, Spitzer G, Taha M, Hamada H, Tsuruo T, Dicke KA.
    Blood; 1989 Nov 01; 74(6):2244-51. PubMed ID: 2572283
    [Abstract] [Full Text] [Related]

  • 5. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
    Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS.
    Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M, De Fabritiis P, Raso V, Greenberger J, Lipton J, Nadler L, Rothstein L, Ritz J, Bast RC.
    Cancer Res; 1986 Mar 01; 46(3):1208-13. PubMed ID: 3510720
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.
    Tong AW, Huang YW, Zhang BQ, Netto G, Vitetta ES, Stone MJ.
    Anticancer Res; 1993 Mar 01; 13(3):593-7. PubMed ID: 8391243
    [Abstract] [Full Text] [Related]

  • 13. The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.
    Musto P, Lombardi G, Matera R, Carotenuto M.
    Haematologica; 1991 Mar 01; 76(6):513-6. PubMed ID: 1687943
    [Abstract] [Full Text] [Related]

  • 14. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC, De Fabritiis P, Lipton J, Gelber R, Maver C, Nadler L, Sallan S, Ritz J.
    Cancer Res; 1985 Feb 01; 45(2):499-503. PubMed ID: 3967224
    [Abstract] [Full Text] [Related]

  • 15. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.
    Grogan T, Dalton W, Rybski J, Spier C, Meltzer P, Richter L, Gleason M, Pindur J, Cline A, Scheper R.
    Lab Invest; 1990 Dec 01; 63(6):815-24. PubMed ID: 1979362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.
    Dalton WS, Durie BG, Alberts DS, Gerlach JH, Cress AE.
    Cancer Res; 1986 Oct 01; 46(10):5125-30. PubMed ID: 2875788
    [Abstract] [Full Text] [Related]

  • 19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 01; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 20. In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.
    den Ouden D, van den Heuvel M, Schoester M, van Rens G, Sonneveld P.
    Leukemia; 1996 Dec 01; 10(12):1930-6. PubMed ID: 8946933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.